Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$10.1M Sell
41,315
-72,595
-64% -$17.9M 0.12% 131
2021
Q1
$28.3M Sell
113,910
-5,360
-4% -$1.28M 0.33% 43
2020
Q4
$27.4M Buy
119,270
+53,195
+81% +$12.3M 0.33% 38
2020
Q3
$16.8M Sell
66,075
-35,657
-35% -$8.83M 0.22% 71
2020
Q2
$24M Sell
101,732
-4,360
-4% -$995K 0.33% 40
2020
Q1
$21.5M Sell
106,092
-6,789
-6% -$1.48M 0.34% 47
2019
Q4
$27.1M Buy
112,881
+1,192
+1% +$263K 0.27% 48
2019
Q3
$21.6M Sell
111,689
-1,369
-1% -$263K 0.24% 57
2019
Q2
$20.8M Buy
113,058
+1,813
+2% +$325K 0.22% 52
2019
Q1
$21.1M Buy
111,245
+8,561
+8% +$1.63M 0.23% 51
2018
Q4
$20M Sell
102,684
-12,093
-11% -$2.36M 0.26% 49
2018
Q3
$23.8M Buy
114,777
+3,444
+3% +$679K 0.23% 56
2018
Q2
$20.6M Sell
111,333
-1,434
-1% -$254K 0.2% 60
2018
Q1
$19.2M Sell
112,767
-12,007
-10% -$2.2M 0.2% 62
2017
Q4
$21.7M Buy
124,774
+6,863
+6% +$1.21M 0.2% 64
2017
Q3
$22M Sell
117,911
-16,420
-12% -$2.91M 0.18% 81
2017
Q2
$23.1M Sell
134,331
-12,473
-8% -$2.03M 0.2% 75
2017
Q1
$24.1M Sell
146,804
-88,951
-38% -$14.8M 0.21% 71
2016
Q4
$34.5M Sell
235,755
-66,186
-22% -$9.96M 0.28% 61
2016
Q3
$50.4M Sell
301,941
-18,504
-6% -$3.13M 0.39% 38
2016
Q2
$48.8M Buy
320,445
+72,530
+29% +$11.3M 0.42% 37
2016
Q1
$37.2M Buy
247,915
+522
+0.2% +$77.6K 0.35% 52
2015
Q4
$40.2M Sell
247,393
-60,962
-20% -$9.58M 0.39% 42
2015
Q3
$42.7M Sell
308,355
-3,104
-1% -$489K 0.45% 39
2015
Q2
$47.8M Sell
311,459
-23,883
-7% -$3.83M 0.59% 26
2015
Q1
$53.6M Sell
335,342
-17,848
-5% -$2.81M 0.61% 24
2014
Q4
$56.3M Buy
353,190
+303,206
+607% +$47.2M 0.65% 21
2014
Q3
$7.02M Buy
49,984
+18,800
+60% +$2.45M 0.19% 123
2014
Q2
$3.69M Buy
31,184
+4,050
+15% +$469K 0.1% 191
2014
Q1
$3.35M Sell
27,134
-4,900
-15% -$594K 0.1% 188
2013
Q4
$3.66M Sell
32,034
-1,720
-5% -$196K 0.14% 141
2013
Q3
$3.78M Sell
33,754
-136,366
-80% -$14.8M 0.16% 144
2013
Q2
$16.9M Buy
+170,120
New +$17.7M 0.59% 43

Other funds holding AMGN

QS Investors's AMGN Position: Q2 2021 in Review

QS Investors reduced its Amgen (AMGN) stake by 64% in Q2 2021, selling an estimated $17.9M and leaving 41,315 shares worth $10.1M. The position accounts for 0.12% of the portfolio, ranked #131.

QS Investors first reported a position in AMGN in Q2 2013 and has held it in 33 quarters since. The position peaked at $56.3M in Q4 2014. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • QS Investors held 41,315 shares of Amgen worth $10.1M as of Q2 2021.
  • QS Investors sold 72,595 Amgen shares in Q2 2021, an estimated $17.9M.
  • Amgen made up 0.12% of QS Investors's portfolio in Q2 2021, its #131 holding.
  • QS Investors first reported a position in Amgen in Q2 2013 and has held it in 33 quarters since.
  • QS Investors's Amgen position peaked at $56.3M in Q4 2014.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.